268 related articles for article (PubMed ID: 12871575)
21. Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV-haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory.
De Bundel D; Demaegdt H; Lahoutte T; Caveliers V; Kersemans K; Ceulemans AG; Vauquelin G; Clinckers R; Vanderheyden P; Michotte Y; Smolders I
J Neurochem; 2010 Mar; 112(5):1223-34. PubMed ID: 20028450
[TBL] [Abstract][Full Text] [Related]
22. Enhanced recombinant expression and purification of human IRAP for biochemical and crystallography studies.
Sui L; Guo HC
Biochem Biophys Rep; 2021 Sep; 27():101042. PubMed ID: 34169156
[TBL] [Abstract][Full Text] [Related]
23. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11.
Demaegdt H; Lukaszuk A; De Buyser E; De Backer JP; Szemenyei E; Tóth G; Chakravarthy S; Panicker M; Michotte Y; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):77-86. PubMed ID: 19643163
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin IV interacts with a juxtamembrane site on AT(4)/IRAP suggesting an allosteric mechanism of enzyme modulation.
Caron AZ; Arguin G; Guillemette G
Regul Pept; 2003 May; 113(1-3):9-15. PubMed ID: 12686456
[TBL] [Abstract][Full Text] [Related]
25. The AT4 receptor agonist [Nle1]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart.
Yang Q; Hanesworth JM; Harding JW; Slinker BK
Regul Pept; 1997 Aug; 71(3):175-83. PubMed ID: 9350976
[TBL] [Abstract][Full Text] [Related]
26. Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory.
Albiston AL; Fernando RN; Yeatman HR; Burns P; Ng L; Daswani D; Diwakarla S; Pham V; Chai SY
Neurobiol Learn Mem; 2010 Jan; 93(1):19-30. PubMed ID: 19660563
[TBL] [Abstract][Full Text] [Related]
27. Identification of modulating residues defining the catalytic cleft of insulin-regulated aminopeptidase.
Ye S; Chai SY; Lew RA; Ascher DB; Morton CJ; Parker MW; Albiston AL
Biochem Cell Biol; 2008 Jun; 86(3):251-61. PubMed ID: 18523486
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxation.
Slinker BK; Wu Y; Brennan AJ; Campbell KB; Harding JW
Cardiovasc Res; 1999 Jun; 42(3):660-9. PubMed ID: 10533606
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
Beyer CE; Dwyer JM; Platt BJ; Neal S; Luo B; Ling HP; Lin Q; Mark RJ; Rosenzweig-Lipson S; Schechter LE
Psychopharmacology (Berl); 2010 May; 209(4):303-11. PubMed ID: 20224888
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
Stragier B; Sarre S; Vanderheyden P; Vauquelin G; Fournié-Zaluski MC; Ebinger G; Michotte Y
J Neurochem; 2004 Sep; 90(5):1251-7. PubMed ID: 15312180
[TBL] [Abstract][Full Text] [Related]
31. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain.
Moeller I; Lew RA; Mendelsohn FA; Smith AI; Brennan ME; Tetaz TJ; Chai SY
J Neurochem; 1997 Jun; 68(6):2530-7. PubMed ID: 9166749
[TBL] [Abstract][Full Text] [Related]
32. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.
Chai SY; Yeatman HR; Parker MW; Ascher DB; Thompson PE; Mulvey HT; Albiston AL
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S14. PubMed ID: 19090987
[TBL] [Abstract][Full Text] [Related]
33. Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.
Stragier B; De Bundel D; Sarre S; Smolders I; Vauquelin G; Dupont A; Michotte Y; Vanderheyden P
Heart Fail Rev; 2008 Sep; 13(3):321-37. PubMed ID: 17990104
[TBL] [Abstract][Full Text] [Related]
34. Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands.
Handa RK; Harding JW; Simasko SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1242-9. PubMed ID: 10565848
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the AT(4) receptor in a human neuroblastoma cell line (SK-N-MC).
Mustafa T; Chai SY; Mendelsohn FA; Moeller I; Albiston AL
J Neurochem; 2001 Mar; 76(6):1679-87. PubMed ID: 11259486
[TBL] [Abstract][Full Text] [Related]
36. Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Hallberg M
Drug News Perspect; 2009 Apr; 22(3):133-9. PubMed ID: 19440555
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation.
Patel JM; Martens JR; Li YD; Gelband CH; Raizada MK; Block ER
Am J Physiol; 1998 Dec; 275(6):L1061-8. PubMed ID: 9843842
[TBL] [Abstract][Full Text] [Related]
38. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.
Stragier B; Demaegdt H; De Bundel D; Smolders I; Sarre S; Vauquelin G; Ebinger G; Michotte Y; Vanderheyden P
Brain Res; 2007 Feb; 1131(1):97-105. PubMed ID: 17169335
[TBL] [Abstract][Full Text] [Related]
39. From angiotensin IV binding site to AT4 receptor.
Vanderheyden PM
Mol Cell Endocrinol; 2009 Apr; 302(2):159-66. PubMed ID: 19071192
[TBL] [Abstract][Full Text] [Related]
40. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
